351 results on '"Desai, Niraj M."'
Search Results
2. Utilization and Outcomes of Abdominal Transplants Using Thoracoabdominal Normothermic Regional Perfusion in Pediatric Donation After Circulatory Death: The United States Experience
3. National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States.
4. A2/A2B to B deceased donor kidney transplantation in the Kidney Allocation System era
5. Wait Time Advantage for Transplant Candidates With HIV Who Accept Kidneys From Donors With HIV Under the HOPE Act
6. Kidney Donation After Circulatory Death Using Thoracoabdominal Normothermic Regional Perfusion: The Largest Report of the United States Experience
7. Kidney Donation After Circulatory Death Using Thoracoabdominal Normothermic Regional Perfusion: The Largest Report of the United States Experience
8. One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial
9. Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients
10. Patient and Graft Survival After A1/A2-incompatible Living Donor Kidney Transplantation
11. 423.2: Patient and Graft Survival After A1/A2-Incompatible Living Donor Kidney Transplantation
12. A2/A2B to B deceased donor kidney transplantation in the Kidney Allocation System era
13. Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A Small Uncontrolled Trial
14. Limited health literacy and adverse outcomes among kidney transplant candidates
15. Who can tolerate a marginal kidney? Predicting survival after deceased donor kidney transplant by donor–recipient combination
16. Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension
17. Imlifidase desensitization in crossmatch-positive, highly-sensitized kidney transplant recipients: Results of an international phase 2 trial (Highdes)
18. Delayed Graft Function in Simultaneous Liver Kidney Transplantation
19. Physical Impairment and Access to Kidney Transplantation
20. Frailty, Inflammatory Markers, and Waitlist Mortality Among Patients With End-stage Renal Disease in a Prospective Cohort Study
21. The effect of induction immunosuppression for kidney transplant on the latent HIV reservoir
22. CHAPTER 112 - Whole organ pancreas and pancreatic islet transplantation
23. Frailty and Postkidney Transplant Health-Related Quality of Life
24. Ethical Considerations Concerning Amnioinfusions for Treating Fetal Bilateral Renal Agenesis
25. Contributors
26. Whole Organ pancreas and pancreatic islet transplantation
27. Frailty, Length of Stay, and Mortality in Kidney Transplant Recipients: A National Registry and Prospective Cohort Study
28. Mortality and Graft Loss Attributable to Readmission After Kidney Transplantation: Immediate and Long-term Risk
29. Successful kidney transplantation from a deceased donor with severe COVID-19 respiratory illness with undetectable SARS-CoV-2 in donor kidney and aorta
30. 1153 A COMPARATIVE EVALUATION OF FIBROSIS AMONG PATIENTS WITH RECURRENT ACUTE AND CHRONIC PANCREATITIS UNDERGOING TOTAL PANCREATECTOMY WITH ISLET AUTOTRANSPLANTATION (TPIAT)
31. Su1453 LARGE DUCT CHRONIC PANCREATITIS AND EXOCRINE INSUFFICIENCY PREDICT INCREASED FIBROSIS IN PATIENTS UNDERGOING TOTAL PANCREATECTOMY WITH ISLET AUTOTRANSPLANTATION (TPIAT)
32. Individual Frailty Components and Mortality in Kidney Transplant Recipients
33. Outcomes and risk stratification for late antibody‐mediated rejection in recipients of ABO‐incompatible kidney transplants: a retrospective study
34. Sex and the single transplanted kidney
35. Serum Sickness After Treatment With Rabbit Antithymocyte Globulin in Kidney Transplant Recipients With Previous Rabbit Exposure
36. Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)
37. Center-Level Variation in the Development of Delayed Graft Function After Deceased Donor Kidney Transplantation
38. Surgical management of early and late ureteral complications after renal transplantation: techniques and outcomes
39. Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results
40. Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C–Viremic Donors to Hepatitis C–Negative Recipients: An Open-Label Nonrandomized Study
41. Sa1423 HISTOLOGIC FIBROSIS IS SIMILAR IN PROXIMAL AND DISTAL PANCREATIC EXCISIONAL BIOPSY SPECIMENS FROM PATIENTS UNDERGOING TPIAT FOR RECURRENT ACUTE AND CHRONIC PANCREATITIS
42. Contributors
43. Whole-organ pancreas and pancreatic islet transplantation
44. Contributors
45. Contributors
46. Pre-Liver Transplantation Locoregional Adjuvant Therapy for Hepatocellular Carcinoma as a Strategy to Improve Longterm Survival
47. Infusion of High-Dose Intravenous Immunoglobulin Fails to Lower the Strength of Human Leukocyte Antigen Antibodies in Highly Sensitized Patients
48. Frailty and Delayed Graft Function in Kidney Transplant Recipients
49. Outcomes of Renal Transplants From Centers for Disease Control and Prevention High-Risk Donors With Prospective Recipient Viral Testing: A Single-Center Experience
50. Multicenter Study to Transplant Hepatitis C–Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.